incretin mimetic agents glp 1 receptor agonists GLP1 Agonists—Effects beyond Obesity and Diabetes GLP-1 receptor agonists review and

A 2025 randomized, double-blind, placebo-controlled trial published in Clinical Nutrition found that 15 mg/day of hydroxytyrosol improved antioxidant and anti-inflammatory status in overweight individuals with prediabetes over 16 weeks, while preserving insulin sensitivity (Moratilla-Rivera et al., 2025)

adults report emotional eating behavior often or very often

Why researchers reach for IGF-1 LR3 ~3 IGF-1 potency Reduced IGF-binding-protein affinity keeps more peptide circulating freely - the basis for its enhanced potency relative to native IGF-1

Additionally, by improving insulin sensitivity and blood sugar regulation, GLP-1 medications help address the metabolic changes that may contribute to abdominal weight gain